What is TheraTrue?
TheraTrue is a prominent medical cannabis company committed to advancing patient well-being through scientific innovation and the development of high-quality, clinically informed products. As a majority Black-owned organization, TheraTrue champions diversity and inclusivity across its leadership and operational framework. The company places a paramount emphasis on safety and security, striving to deliver reliable solutions for individuals managing qualified medical conditions. With a robust backing exceeding $50 million and an esteemed Medical Advisory Board comprising over 20 physicians and pharmacists, TheraTrue is strategically positioned to lead in the evolving medical cannabis landscape.
How much funding has TheraTrue raised?
TheraTrue has raised a total of $50M across 1 funding round:
Unspecified
$50M
Unspecified (2021): $50M, investors not publicly disclosed
What's next for TheraTrue?
The recent major strategic investment into TheraTrue signals a pivotal phase for the company, likely aimed at scaling operations, expanding research and development initiatives, and potentially broadening its market reach. This enterprise-level capital infusion suggests confidence from investors in TheraTrue's business model and its capacity to navigate the complex regulatory environment of the medical cannabis industry. Future endeavors may include further clinical trials, new product formulations, and strategic partnerships to enhance patient access and therapeutic outcomes. The company's commitment to science and patient care, coupled with its emphasis on diversity, positions it for sustained growth and impact.
See full TheraTrue company page
